Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Aktiebolaget Biopharmacon
AB
Active
Org 5563302453
Sveavägen 8, 752 36
Uppsala
Business and other management consultancy activities
· NACE 7020
Est. 1988
1 employees
Watchlist
Share
Sweden
/
Companies
/
Business and other management consultancy activities
/
Aktiebolaget Biopharmacon
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
411
243
382
480
366
Staff expenses
—
—
−57
−63
−57
EBITDA
100
16
−35
62
−53
Depreciation & amort.
−0
−0
—
—
—
EBIT
100
16
−35
62
−53
Net financials
−22
1 976
56
163
151
Profit before tax
263
2 269
89
170
295
Tax
−62
−57
−22
−38
−66
Net profit
201
2 212
67
133
229
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
4 833
6 790
6 807
7 075
7 035
Equity
4 121
6 332
6 399
6 532
6 761
Long-term debt
0
0
—
—
—
Short-term debt
107
67
86
166
94
Total debt
107
67
86
166
94
Financial ratios
5-year trend
EBITDA margin
-14.4%
This company
15.8%
Market median
-191% vs market
2021
2025
Equity ratio
96.1%
This company
38.2%
Market median
+152% vs market
2021
2025
Return on equity
3.4%
This company
18.4%
Market median
-82% vs market
2021
2025
Net profit margin
62.6%
This company
8.1%
Market median
+673% vs market
2021
2025
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
2021
2025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
View
PDF
More on Aktiebolaget Biopharmacon
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
